Sun Pharmaceutical Industries Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
4/10
|
40.29 | 59.48 | -32.27% | 41.83 | -3.68% |
| P/S |
|
8.08 | 18.4 | -56.1% |
|
|
| P/BV |
|
5.75 | 8.7 | -33.88% |
|
|
| P/FCF |
|
27.38 | -381.81 | -107.17% |
|
|
| Ev/Ebitda |
|
19.65 | 4.22 | 366.27% |
|
|
| Ev/S |
|
4.98 | 14.52 | -65.68% |
|
|
| Ev/FCF |
|
23.96 | -314.48 | -107.62% |
|
|
| E/P |
|
0.0352 | 0.0159 | 121.16% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
25.36 | -32.76 | -177.4% | 21.56 | +17.61% |
| ROE |
|
16.01 | 3.58 | 346.98% |
|
|
| ROA |
|
11.52 | 3.38 | 241% |
|
|
| ROIC |
|
18.19 | 11.26 | 61.5% |
|
|
| ROS |
|
20.05 | -47.93 | -141.84% |
|
|
| ROCE |
|
13.77 | -3.43 | -501.18% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.235 | -0.571 | -141.15% | 0.3533 | -33.48% |
| Nеt Debt/Ebitda |
|
-0.5318 | -0.2949 | 80.31% |
|
|
| Debt/Ratio |
|
0.0333 | 0.1259 | -73.56% |
|
|
| Debt/Equity |
|
0.2506 | 0.4057 | -38.22% |
|
|
| Debt/Net Income |
|
0.2972 | 1.67 | -82.26% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
2/10
|
0.7991 | 0.6379 | 25.26% | 0.8964 | -10.85% |
| Number of years of dividend growth |
|
5 | 0.84 | 495.24% | ||
| DSI |
|
1 | 0.8171 | 22.38% |
|
|
| Average dividend growth |
|
28.19 | 0.8603 | 3176.22% |
|
|
| Average percentage for 5 years |
|
0.8964 | 0.8744 | 2.52% |
|
|
| Average percentage for payments |
|
28.64 | 22.22 | 28.92% |
|
|
| Difference from average difference in sector |
|
0.1612 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
6/10
|
45.44 | 72.61 | -37.42% | ||
| Growth impulse Ebitda in 5 years |
|
98.89 | 72.97 | 35.52% | ||
| Growth impulse Net Income in 5 years |
|
154.36 | 159.06 | -2.95% | ||
| Growth impulse FCF in 5 years |
|
98.16 | 85.72 | 14.51% | ||
| Growth impulse EPS in 5 years |
|
154.36 | 36.2 | 326.41% |
IP Score
7.05/10
